Validated HPLC Method for the Pharmacokinetic Study of Atenolol andChlorthalidone Combination Therapy in Korean Subjects

다국어 초록 (Multilingual Abstract)

A rapid, selective and sensitive reverse-phase HPLC methods for the determination of atenolol and chlorthalidone in human serum and whole blood were validated, and applied to the pharmacokinetic study of atenolol and chlorthalidone combination therapy. Atenolol and an internal standard, pindolol, were extracted from human serum by liquid-liquid extraction, and analyzed on a -Bondapak C18 10-mm column in a mobile phase of methanol-0.01 M potassium dihydrogenphosphate (30:70, v/v, adjusted to pH 3.5) and fluorescence detection (emission: 300 nm, excitation: 224 nm). Chlorthalidone and an internal standard, probenecid, were extracted form human whole blood by liquid-liquid extraction, and analyzed on a Luna C18 5-m column in a mobile phase of acetonitrile containing 77% 0.01 M sodium acetate and UV detection at 214 nm. These analysis were performed at three different laboratories using the same quality control (QC) samples. The chromatograms showed good resolution, sensitivity, and no interference by human serum and whole blood, respectively. The methods showed linear responses over a concentration range of 10-1,000 ng/mL for atenolol and 0.05-20 g/mL for chlorthalidone, with correlation coefficients of greater than 0.999 at all the three laboratories. Intra- and inter-day assay precision and accuracy fulfilled international requirements. Stability studies (freeze-thaw, short-, long-term, extracted sample and stock solution) showed that atenolol and chlorthalidone were stable. The lower limit of quantitation of atenolol and chlorthalidone were 10 ng/mL and 0.05 g/mL, respectively, which was sensitive enough for pharmacokinetic studies. These methods were applied to the pharmacokinetic study of atenolol and chlorthalidone in human volunteers following a single oral administration of Hyundai Tenoretic?? tablet (atenolol 50 mg and chlorthalidone 12.5 mg) at three different laboratories.

참고문헌 (Reference)

1 "sensitive and selective high-performance liquid chromatographic method for analysis of chlorthalidone in whole blood" 416 : 420-425, 1987

2 "Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography" 21 : 1137-1142, 2000

3 "Simul- taneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography Application to pharmacokinetic studies in man" 698 : 187-194, 1997

4 "Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS" 156 (156): 106-117, 2006

5 "Martindale-The complete drug reference 32nd ed." Pharmaceutical Press 825-, 1999

6 "Korea Food & Drug Administration Notification No. 200260, Standard Protocol of Bioequivalence Test" 2002.11.

7 "Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation" 17 (17): 507-513, 1998

8 "Determination of biological equivalence of two atenolol preparation" 25 (25): 567-571, 1987

9 "Comparative bioavilability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination" 50 (50): 802-808, 2000

10 "Comparative Bioavailability of Two Brands of Atenolol 100 mg Tablets (Tensotin and Tenormin) in Healthy Human Volunteers" 26 : 1-5, 2005

11 "Bioavailability in man of atenolol and chlorthalidone from a combination formulation" 7 (7): 223-231, 1986

12 "Bioavail- ability in man of atenolol and chlorthalidone from a combination formulation" 147-156, 1981

13 "Bio- equivalence of Samchundang Atenolol Tablet to Tenolmin Tablet" 47 (47): 339-344, 2003

14 "Analysis of chlorthalidone in whole blood by high-performance liquid chromatography" 375 : 438-443, 1986

15 "A micromethod for the quantification of atenolol in plasma using high-performance liquid chroma- tography with fluorescence detection: Therapeutic drug monitoring of two patients with severe coronary insufficiency before cardiac surgery" 28 (28): 237-244, 2006